Thoracic Tumours Register
RTT
1 other identifier
observational
10,000
1 country
79
Brief Summary
Observational, multicenter study in patients with lung cancer and other thoracic tumors. The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents and molecular inhibitors of cell proliferation as one of its primary objectives. This could significantly improve the prognosis of patients with lung cancer, and will lead to a radical change in routine clinical practice. The aim of the register is to explore all data available of all patients treated because of thoracic tumours.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2016
Longer than P75 for all trials
79 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 21, 2016
CompletedFirst Submitted
Initial submission to the registry
October 19, 2016
CompletedFirst Posted
Study publicly available on registry
October 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2031
April 23, 2026
April 1, 2026
14.5 years
October 19, 2016
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Describe epidemiology characteristics of lung cancer and other thoracic tumors in Spanish people
To know the epidemiology characteristics of lung cancer and other thoracic tumors in Spain, as well as clinical and histological data, diagnosis, treatments received, and prognostic factors
up to 10 years
Study Arms (5)
Non-small cell lung cancer
patients treated for a non small cell lung cancer
Small cell lung cancer
patients treated for a small cell lung cancer
Mesotelioma
patients treated for a mesotelioma
timic cancer
patients treated for a timic cancer
carcinoid cancer
patients treated for a carcinoid cancer
Eligibility Criteria
All patients treated due to a thoracic tumour
You may qualify if:
- Patients with thoracic disease, treated with an active treatment or not treated (only palliative care)
You may not qualify if:
- Patients with other type of tumours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (79)
Complejo Hospitalario Universitario de Ferrol
Ferrol, A Coruña, Spain
Complejo Hospitalario Universitario de Albacete
Albacete, Albacete, 05200, Spain
H. Virgen de los Lirios
Alcoy, Alicante, 03804, Spain
Hospital General de Alicante
Alicante, Alicante, 03010, Spain
Hospital de Elche
Elche, ALICANTE, 03202, Spain
Hospital General de Elda
Elda, Alicante, 03600, Spain
H. Germans Trias i Pujol
Badalona, BARCELONA, 08916, Spain
Clinica Tres Torres
Barcelona, Barcelona, 08017, Spain
IOB Hospital Quirón Salud Barcelona
Barcelona, Barcelona, 08023, Spain
HM Hospital Ntra. Sra. de la Esperanza
Barcelona, Barcelona, 08024, Spain
Hospital de La Santa Creu I Sant Pau
Barcelona, Barcelona, 08041, Spain
Hospital de Granollers
Granollers, Barcelona, 08402, Spain
Hospital de Mataró
Mataró, Barcelona, 08304, Spain
Consorci Sanitari de Terrassa
Terrassa, Barcelona, 08220, Spain
Hospital de Burgos
Burgos, Burgos, Spain
H. Provincial de Castellón
Castelló, Castelló, 12002, Spain
Hospital General La Mancha Centro
Alcázar de San Juan, Ciudad Real, 13600, Spain
Hospital General Universitario de Ciudad Real
Ciudad Real, Ciudad Real, 13005, Spain
Complejo Hospitalario de la Coruña
A Coruña, Coruña, 15006, Spain
Hospital Virgen de la Luz
Cuenca, Cuenca, 16002, Spain
Hospital San Pedro de Alcántara
Cáceres, Cáceres, 10003, Spain
Hospital Dr. Josep Trueta
Girona, Girona, 17007, Spain
H. Insular de Gran Canarias
Las Palmas de Gran Canaria, Gran Canarias, 35016, Spain
H. Virgen de las Nieves
Granada, Granada, 18014, Spain
Oncogranada
Granada, Granada, 18014, Spain
Hospital Universitari de Guadalajara
Guadalajara, Guadalajara, 19002, Spain
Hospital de Jaén
Jaén, Jaén, 23007, Spain
Complejo Asistencial Universitario de León
León, León, 24071, Spain
Hospital Universitario Lucus Augusti
Lugo, Lugo, Spain
Hospital Príncipe de Asturias
Alcalá de Henares, Madrid, 28805, Spain
Hospital Universitario Fundación Alcorcón
Alcorcón, Madrid, 28922, Spain
Hospital HLA Moncloa
Aravaca, Madrid, 28008, Spain
H. Fuenlabrada
Fuenlabrada, Madrid, 28942, Spain
Hospital La Princesa
Madrid, Madrid, 28006, Spain
H.U. Puerta de Hierro
Madrid, Madrid, 28035, Spain
Fundación Jimenez Diaz
Madrid, Madrid, 28040, Spain
Imoncology
Madrid, Madrid, 28043, Spain
Hospital Universitario Sanchinarro
Madrid, Madrid, 28050, Spain
Hospital Universitario Infanta Sofía
Madrid, Madrid, 28703, Spain
H. Clínico San Carlos
Madrid, Madrid, Spain
H. La Paz
Madrid, Madrid, Spain
Hospital General Universitario Gregorio Marañón
Madrid, Madrid, Spain
Hospital Universitario de Móstoles
Móstoles, Madrid, Spain
Hospital Universitario Infanta Cristina
Parla, Madrid, 28981, Spain
Hospital Universitario Quirón Madrid
Pozuelo de Alarcón, Madrid, Madrid, Spain
Hospital General Universitario Santa Lucía
Cartagena, Murcia, 30202, Spain
H. Morales Messeguer
Murcia, Murcia, 30008, Spain
Hospital Clínico Universitario Virgen de la Arrixaca
Murcia, Murcia, 30120, Spain
Hospital Quirón Salud Málaga
Málaga, Málaga, 29004, Spain
H. Carlos Haya
Málaga, Málaga, 29010, Spain
Hospital Virgen de la Victoria
Málaga, Málaga, 29010, Spain
Clínica Universitaria de Navarra
Pamplona, Navarre, 31008, Spain
Complejo Hospitalario de Navarra
Pamplona, Navarre, 31008, Spain
Hospital Reina Sofía
Tudela, Navarre, 31500, Spain
Hospital Santa María Naí
Ourense, Ourense, Spain
Hospital Son Espases
Palma de Mallorca, Palma de Mallorca, 07010, Spain
Complejo Hospitalario de Vigo
Vigo, Pontevedra, 36212, Spain
Hospital Clinico de Salamanca
Salamanca, SALAMANCA, 37007, Spain
H. de Donostia
Donostia / San Sebastian, San Sebastian, 20014, Spain
Hospital Nuestra Señora Candelaria
Santa Cruz de Tenerife, Santa Cruz de Tenerife, 38010, Spain
Hospital de Segovia
Segovia, Segovia, 40002, Spain
Hospital Virgen del Rocío
Seville, Sevilla, 41013, Spain
Hospital Sant Joan de Reus
Reus, Tarragona, 43204, Spain
Hospital Sant Pau i Santa Tecla
Tarragona, Tarragona, 43003, Spain
Hospital Universitari de Tarragona Joan XXIII
Tarragona, Tarragona, 43005, Spain
Hospital Verge de la Cinta
Tortosa, Tarragona, Spain
H. Universitario de Canarias
San Cristóbal de La Laguna, Tenerife, 38320, Spain
Hospital Virgen de la Salud
Toledo, Toledo, 45005, Spain
Hospital Universitari de la Ribera
Alzira, Valencia, 46600, Spain
Instituto Valenciano de Oncología
Valencia, Valencia, 46009, Spain
H. General U. de Valencia
Valencia, Valencia, 46014, Spain
H. Arnau de Vilanova Valencia
Valencia, Valencia, 46015, Spain
Hospital Dr. Peset
Valencia, Valencia, 46017, Spain
Hospital La Fe
Valencia, Valencia, 46026, Spain
Hospital Lluís Alcanyís
Xàtiva, Valencia, 46800, Spain
Hospital Clínico Universitario de Valladolid
Valladolid, Valladolid, 47003, Spain
Hospital de Basurto
Bilbao, VIZCAYA, 48013, Spain
Complejo Asistencial de Zamora
Zamora, Zamora, 49022, Spain
Hospital Universitario de Áraba
Vitoria-Gasteiz, Áraba, 01009, Spain
Related Publications (2)
Provencio M, Cobo M, Rodriguez-Abreu D, Carcereny E, Calvo V, Castro RL, Bernabe R, Bruno MF, Bosch-Barrera J, Barco ED, Medina K, Sanchez-Hernandez A, Suay G, Ortega AL, Vazquez S, Lazaro-Quintela M, Guirado M, Estival A, Blanco M, Cantero A, Massuti B. Biomarker landscape in advanced NSCLC: insights from a national prospective registry. Lung Cancer. 2025 Sep;207:108680. doi: 10.1016/j.lungcan.2025.108680. Epub 2025 Jul 28.
PMID: 40749260DERIVEDProvencio M, Cobo M, Rodriguez-Abreu D, Carcereny E, Cantero A, Calvo V, Lopez Castro R, Bernabe R, Bosch-Barrera J, Massuti B, Garcia Campelo R, Sanchez-Hernandez A, Laura Ortega A, Guirado M, Del Barco E, Camps C, Casal-Rubio J, Domine M, Angeles Sala M, Padilla A, Luis Gonzalez Larriba J, de Asis Aparisi F; Spanish Lung Cancer Group SLCG/GECP. Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry. Lung Cancer. 2024 Apr;190:107513. doi: 10.1016/j.lungcan.2024.107513. Epub 2024 Feb 29.
PMID: 38432027DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Mariano Provencio, MD
Hospital Puerta del Hierro
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2016
First Posted
October 21, 2016
Study Start
July 21, 2016
Primary Completion (Estimated)
December 30, 2030
Study Completion (Estimated)
December 30, 2031
Last Updated
April 23, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share